Table 2 Principal elements of the studies which formed part of the present systematic analysis
Author | Year | Nationality | Number of study participants | Age of study participants | Diagnostic criteria | Prevalence of TMD before treatments | Prevalence of TMD after treatments |
|---|---|---|---|---|---|---|---|
Pancherz | 1982 | Sweden | 20 patients | 11–14 yrs | Helkimo index | Symptomatic: 20% Asymptomatic: 80% | Symptomatic: 45% Asymptomatic: 55% |
Aidar | 2013 | Brazil | 32 patients | 12.8 yrs | Hellkimo index | Asymptomatic: 18,75% Mild dysfunction: 75% Severe: 6,25% | Asymptomatic: 18,75% Mild: 78,15% Severe: 3,12% |
Ruf and Bock | 2019 | Germany | 72 patients | 13.4 yrs | Helkimo index RDC/TMD | Symptomatic: 38.5% Asymptomatic: 61,5% | Symptomatic: 27,3% Asymptomatic: 72,7% |
Ruf | 1999 | Germany | 62 patients | RDC/TMD | Manual Functional analysis (MFA) | Symptomatic: 6,45% Asymptomatic: 93,55% | Symptomatic: 14,51% Asymptomatic: 85,49% |